CD8A and cancer: Within tumors, higher proportions of cytotoxic T lymphocytes (CD8+ cells) have been associated with more favorable cancer outcomes, whereas higher proportions of regulatory T cells (Treg) have been associated with immunosuppression, accelerated cancer development, and decreased survival (7–10).